These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7448820

  • 1. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G, Wu SJ.
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV, Murphy S, Huguley CM, Bartolucci AA.
    Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A case of advance colon cancer responding to sequential methotrexate and 5-fluorouracil therapy].
    Iida A, Komatsu T, Ookubo K, Ikeda N.
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):661-3. PubMed ID: 8470927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
    Klaassen U, Wilke H, Müller C, Borquez D, Harstrick A, Seeber S.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
    [Abstract] [Full Text] [Related]

  • 10. Sequential methotrexate and 5-FU in breast cancer resistant to the conventional application of these drugs.
    Herrmann R, Manegold C, Schroeder M, Tigges FJ, Bartsch H, Jungi F, Fritze D.
    Cancer Treat Rep; 1984 Oct; 68(10):1279-81. PubMed ID: 6525599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
    Weinerman B, Schacter B, Schipper H, Bowman D, Levitt M.
    Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
    [Abstract] [Full Text] [Related]

  • 16. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
    O'connor T, Rustum Y, Levine E, Creaven P.
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):125-31. PubMed ID: 17426973
    [Abstract] [Full Text] [Related]

  • 17. [Sequential methotrexate and 5-fluorouracil].
    Sasaki T.
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
    [Abstract] [Full Text] [Related]

  • 18. Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy.
    Fryar EB, Das JR, Davis JH, Desoto JA, Laniyan I, Southerland WM, Bowen D.
    Anticancer Res; 2006 Dec; 26(3A):1861-7. PubMed ID: 16827118
    [Abstract] [Full Text] [Related]

  • 19. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann J, Kennedy I, Barrett-Lee P, Perren T, Verrill M, Cameron D, Foster E, Yellowlees A, Crown J, Anglo-Celtic Cooperative Oncology Group.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1076-83. PubMed ID: 15265969
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
    Sobrero A, Frassineti G, Falcone A, Dogliotti L, Rosso R, Di Costanzo F, Bruzzi P, INTACC.
    Br J Cancer; 2005 Jan 17; 92(1):24-9. PubMed ID: 15611795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.